Tb Screening: Foreign Student University Entry Requirements

Tuberculosis (TB) is a serious health concern for colleges and universities, given the high degree of person-to-person interaction and crowded living conditions on campuses. In the US, there is no federal law requiring international students to undergo health screening or obtain vaccinations before arrival. However, individual colleges and universities may have their own TB screening requirements for incoming international students, particularly those from countries with a high incidence of TB. This is often in the form of a tuberculin skin test (TST) or a TB blood test. Some institutions also require chest X-rays for students with positive TB test results. While these requirements vary across institutions, they are generally implemented to protect the health of both individual students and the wider campus community.

Tuberculosis (TB) testing is recommended for foreign-born students with identifiable risk factors for exposure to TB and/or active TB disease

In the US, there is no federal law requiring temporary visitors, including international students, to undergo health screening or obtain vaccinations before arrival. However, the American College Health Association (ACHA) recommends that colleges and universities implement TB testing for foreign-born students with identifiable risk factors for exposure to TB and/or active TB disease. This is particularly important for students coming from countries with a high prevalence of TB, such as China, India, and South Korea, which have some of the highest incidence rates of TB in the world.

Many educational institutions in the US rely on the tuberculin skin test (TST) for their TB testing. However, this test requires multiple visits to the student health centre and can lead to missed follow-ups and delayed results. Additionally, the TST can cross-react with the bacille Calmette-Guérin (BCG) vaccine, which is used in many countries with a high prevalence of TB, potentially resulting in false-positive results.

As an alternative to the TST, some institutions offer the T-SPOT.TB test, which only requires one blood collection tube and a single visit. This test has a sensitivity and specificity of >95% and does not require on-site incubation or refrigeration.

Regardless of the test used, it is important for colleges and universities to have comprehensive student health policies in place to mitigate the risk of TB transmission. This includes ensuring that students with positive TB tests receive appropriate treatment and are not discriminated against. It is also crucial for institutions to have plans for providing necessary clinical follow-up and treatment for students identified with latent TB infection or active TB disease.

In summary, while TB testing may not be legally required for all foreign-born students, it is recommended for those with identifiable risk factors, and institutions should have appropriate policies and procedures in place to protect the health and safety of their students and the wider community.

The tuberculin skin test (TST) is often used for TB testing, but it requires multiple visits and can lead to false positives

The tuberculin skin test (TST) is a traditional method of TB testing that is still used today. It involves injecting a purified protein derivative (PPD) solution under the skin, usually on the forearm. The solution is derived from tuberculin and causes a T-cell-mediated delayed-type hypersensitivity reaction in those infected with TB bacteria. Typically, it takes between two to eight weeks after the initial infection for the TB skin test to detect the bacteria.

While the TST is simple to perform and does not require laboratory equipment or phlebotomy, it does have some drawbacks. It requires trained personnel to administer and interpret the results, and the solution must be correctly refrigerated and stored according to an inventory plan. One of the most significant disadvantages of the TST is that it requires two or more patient visits. The patient must return within 48 to 72 hours so that a healthcare provider can assess the skin's reaction to the injection. This can be inconvenient for patients and may result in missed follow-up appointments.

Another concern with the TST is the possibility of false-positive results. Previous vaccination with the bacille Calmette-Guérin (BCG) vaccine or infection with nontuberculous mycobacteria can lead to false positives. The BCG vaccine is commonly used in countries with a high prevalence of TB, and it can cause a cross-reaction with the TST. This means that a person who has received the BCG vaccine may test positive on a TST even if they are not infected with TB. False positives can lead to unnecessary and costly further testing, such as X-rays and treatment.

Due to these limitations, the TST may not be the most efficient or accurate method for TB testing, especially for international students who may have received the BCG vaccine.

The T-SPOT.TB test is an alternative TB test with sensitivity and specificity > 95%

The T-SPOT.TB test is a promising alternative to the 100-year-old tuberculin skin test (TST) for tuberculosis (TB) testing in foreign students. The TST requires multiple visits to the health centre, which can lead to missed follow-ups and delayed results. It can also cross-react with the bacille Calmette–Guérin (BCG) vaccine, leading to false positives. The T-SPOT.TB test, on the other hand, is a one-visit test with a sensitivity and specificity of >95%. It is also reliable for immunocompromised individuals.

The T-SPOT.TB test is an interferon-gamma release assay (IGRA) that detects interferon-γ secreted by T cells in response to specific antigens from Mycobacterium tuberculosis. It is based on the T-cell-mediated immune response to TB infection. The test uses peripheral blood mononuclear cells (PBMCs) and specific T cell responses to RD1-encoded antigens. The response is considered positive when the antigen well contains six or more spots and has twice the number of spots than the negative control well.

The T-SPOT.TB test has been found to be more sensitive and specific for diagnosing active TB than the TST, especially in BCG-vaccinated populations. However, it may not be suitable for elderly patients due to a higher risk of false-negative and false-positive results. The test is also influenced by certain factors such as smoking history, diabetes, and previous TB infection.

In summary, the T-SPOT.TB test is a promising diagnostic tool for active TB, particularly in BCG-vaccinated populations. It offers improved specificity and can replace the TST. The test may also be useful for assessing treatment outcomes as its sensitivity decreases with anti-TB treatment.

The US Center for Disease Control and Prevention (CDC) recommends screening individuals from countries where TB is endemic or relatively common

In the US, there is no federal law requiring temporary visitors, including international students, to undergo health screening or obtain vaccinations before arrival. However, applicants for permanent US residency are required by law to undergo a pre-arrival medical evaluation.

The CDC's recommendation for TB screening of individuals from countries where TB is endemic is aimed at protecting both the health of the students being tested and the wider university community. A TB test can detect any form of TB infection, which is the first step in making a diagnosis and securing treatment if necessary.

Some US colleges and universities have implemented TB-screening policies for all newly enrolled international students, particularly those from countries with high TB incidence rates. For example, the University of North Carolina at Chapel Hill requires incoming international students to be screened for TB within the United States according to standard guidelines. The University of Memphis also requires students from TB-endemic countries to undergo a TB skin test upon arrival on campus.

The Minnesota Department of Health (MDH) has developed guidelines emphasizing that universal tuberculin skin testing of all students is not recommended. Instead, screening should be targeted at students at the highest risk for TB, specifically international students from or travelling to countries where TB is endemic.

The American College Health Associates (ACHA) recommends TB testing for foreign-born students with identifiable risk factors for exposure to TB and/or active TB disease. However, the traditional tuberculin skin test (TST) can lead to cross-reaction and false positives for individuals who have received the BCG vaccine, which is used in many countries with a high prevalence of TB. As a result, alternative TB tests such as the T-SPOT.TB test have been developed to improve accuracy and reduce the need for multiple visits to the student health centre.

Students from countries with an increased incidence of TB or who have spent time in such a country must provide documentation of TB screening

Colleges and universities in the United States are at risk of communicable disease outbreaks due to the high level of person-to-person interaction and crowded dormitory settings. Tuberculosis (TB) is one of the diseases of concern, with international students potentially contributing to the burden of TB in the US. In the 2012/2013 school year, US colleges and universities enrolled approximately 820,000 international students, some of whom have not taken any health-related precautions before travelling. A large proportion of these students come from countries with some of the highest incidence rates of TB in the world, including China, India and South Korea.

The American College Health Association (ACHA) publishes recommendations for TB screening to help colleges and universities develop comprehensive student health policies to mitigate disease transmission. However, there is no federal law requiring temporary visitors, including international students, to undergo health screening or obtain vaccinations before arrival in the US.

Despite this, many colleges and universities in the US have their own policies and requirements for TB screening of international students. For example, the University of North Carolina at Chapel Hill requires incoming international students from countries with an increased incidence of TB, or who have spent more than one month in such a country, to provide documentation of TB screening. Acceptable tests include the Tuberculin Skin Test (TST) or a TB blood test (QFT-G or T-spot), which must have been conducted within the 12 months prior to the first day of classes. The University of Memphis also requires students from TB-endemic countries to undergo a TB skin test upon arrival on campus, at a cost of $38.

In Minnesota, the Department of Health has developed guidelines that recommend targeted tuberculin skin testing for all international students from countries where TB is endemic, as well as for students whose studies involve extensive international travel to areas where TB is endemic.

These requirements and recommendations are in place to protect the health of the students being tested, as well as the wider university community. A TB test can detect any form of TB infection, allowing for appropriate treatment to be administered if necessary.

Frequently asked questions